Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8db2889ce927060a670f07b97e9cc8d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-52 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9166c78889f2d074ad93fcb5d0f7dcf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_546706cdbf060dcecfd76ac32d8f109c |
publicationDate |
2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015265706-A1 |
titleOfInvention |
Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (pepst) and exciton-plasmon enhanced phototherapy (epep) |
abstract |
The use of plasmonics enhanced photospectral therapy (PEPST) and exiton-plasmon enhanced phototherapy (EPEP) in the treatment of various cell proliferation disorders, and the PEPST and EPEP agents and probes used therein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9682250-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363541-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11452983-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331019-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498643-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11531025-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020180444-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017127759-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018222798-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207409-B2 |
priorityDate |
2007-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |